merged_eli-lilly-zepbound-price.txt
<question_number>1</question_number>
<answer>Lilly is positioning its vials as a safer option than compounded drugs due to compounded drugs being subject to far less oversight than traditionally approved medications</answer>

<question_number>2</question_number>
<answer>Like compounded drugs prescribed by online startups, Zepbound vials can be delivered right to patients' doors through LillyDirect</answer>

<question_number>3</question_number>
<answer>Compounded drugs are subject to far less oversight than traditionally approved medications</answer>

<question_number>4</question_number>
<answer>Outside experts said the move could help Lilly regain customers who are currently getting compounded tirzepatide</answer>

<question_number>5</question_number>
<answer>Compounding pharmacies can make copycat versions of any medication the FDA lists as "in shortage," and when off the shortage list, there should be no space for mass compounders</answer>

<question_number>6</question_number>
<answer>N/A</answer>

<question_number>7</question_number>
<answer>Older patients may experience loss of muscle mass that may make people over 65 more likely to suffer fractures or become frail</answer>

<question_number>8</question_number>
<answer>Lilly is positioning its vials as a safer option than compounded drugs for people who cannot afford its pens</answer>

<question_number>9</question_number>
<answer>Being listed as "in shortage" by the FDA</answer>

<question_number>10</question_number>
<answer>Lower pricing</answer>